Young EJ - Search Results

1

MT-125 Inhibits Non-Muscle Myosin IIA and IIB, Synergizes with Oncogenic Kinase Inhibitors, and Prolongs Survival in Glioblastoma.

Kenchappa R, Radnai L, Young EJ, Zarco N, Lin L, Dovas A, Meyer CT, Haddock A, Hall A, Canoll P, Cameron MD, Nagaiah NK, Rumbaugh G, Griffin PR, Kamenecka TM, Miller CA, Rosenfeld SS. Kenchappa R, et al. Among authors: young ej. bioRxiv [Preprint]. 2024 Apr 29:2024.04.27.591399. doi: 10.1101/2024.04.27.591399. bioRxiv. 2024. PMID: 38746089 Free PMC article. Preprint.

2

Myosin II motor activity in the lateral amygdala is required for fear memory consolidation.

Gavin CF, Rubio MD, Young E, Miller C, Rumbaugh G. Gavin CF, et al. Learn Mem. 2011 Dec 14;19(1):9-14. doi: 10.1101/lm.024042.111. Print 2012 Jan. Learn Mem. 2011. PMID: 22174310 Free PMC article.

3

MicroRNA-182 regulates amygdala-dependent memory formation.

Griggs EM, Young EJ, Rumbaugh G, Miller CA. Griggs EM, et al. Among authors: young ej. J Neurosci. 2013 Jan 23;33(4):1734-40. doi: 10.1523/JNEUROSCI.2873-12.2013. J Neurosci. 2013. PMID: 23345246 Free PMC article.

4

Selective, retrieval-independent disruption of methamphetamine-associated memory by actin depolymerization.

Young EJ, Aceti M, Griggs EM, Fuchs RA, Zigmond Z, Rumbaugh G, Miller CA. Young EJ, et al. Biol Psychiatry. 2014 Jan 15;75(2):96-104. doi: 10.1016/j.biopsych.2013.07.036. Epub 2013 Sep 5. Biol Psychiatry. 2014. PMID: 24012327 Free PMC article.

5

The Actin Cytoskeleton as a Therapeutic Target for the Prevention of Relapse to Methamphetamine Use.

Young EJ, Briggs SB, Miller CA. Young EJ, et al. CNS Neurol Disord Drug Targets. 2015;14(6):731-7. doi: 10.2174/1871527314666150529145531. CNS Neurol Disord Drug Targets. 2015. PMID: 26022262 Free PMC article. Review.

6

Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use.

Young EJ, Blouin AM, Briggs SB, Daws SE, Lin L, Cameron MD, Rumbaugh G, Miller CA. Young EJ, et al. Mol Psychiatry. 2016 May;21(5):615-23. doi: 10.1038/mp.2015.103. Epub 2015 Aug 4. Mol Psychiatry. 2016. PMID: 26239291 Free PMC article.

7

Nonmuscle myosin II inhibition disrupts methamphetamine-associated memory in females and adolescents.

Young EJ, Briggs SB, Rumbaugh G, Miller CA. Young EJ, et al. Neurobiol Learn Mem. 2017 Mar;139:109-116. doi: 10.1016/j.nlm.2017.01.001. Epub 2017 Jan 7. Neurobiol Learn Mem. 2017. PMID: 28082169 Free PMC article.

8

Memory disrupting effects of nonmuscle myosin II inhibition depend on the class of abused drug and brain region.

Briggs SB, Blouin AM, Young EJ, Rumbaugh G, Miller CA. Briggs SB, et al. Among authors: young ej. Learn Mem. 2017 Jan 17;24(2):70-75. doi: 10.1101/lm.043976.116. Print 2017 Feb. Learn Mem. 2017. PMID: 28096495 Free PMC article.

9

The role of nonmuscle myosin II in polydrug memories and memory reconsolidation.

Briggs SB, Hafenbreidel M, Young EJ, Rumbaugh G, Miller CA. Briggs SB, et al. Among authors: young ej. Learn Mem. 2018 Aug 16;25(9):391-398. doi: 10.1101/lm.046763.117. Print 2018 Sep. Learn Mem. 2018. PMID: 30115760 Free PMC article.

10

Methamphetamine Learning Induces Persistent and Selective Nonmuscle Myosin II-Dependent Spine Motility in the Basolateral Amygdala.

Young EJ, Lin H, Kamenecka TM, Rumbaugh G, Miller CA. Young EJ, et al. J Neurosci. 2020 Mar 25;40(13):2695-2707. doi: 10.1523/JNEUROSCI.2182-19.2020. Epub 2020 Feb 17. J Neurosci. 2020. PMID: 32066582 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters